Dimethylformamide

Dimethylformamide

SCHEMBL133174

CCCC.CCOC(C)OCC.CN(C)C=O

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.55
TSHR P16473 1/20 0.41
THRB P10828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dimethylformamide SCHEMBL314310 0.95 LMNA (0.60) LMNATSHRTHRB
Dimethylformamide SCHEMBL131192 0.91 LMNA (0.55) LMNATSHRTHRB
Butane SCHEMBL11540528 0.85 LMNA (0.48) LMNA
Dimethylformamide SCHEMBL9464389 0.83 TSHR (0.47) LMNATSHRTHRB
Butane SCHEMBL2557609 0.83 LMNA (0.63) LMNATHRB
Butane SCHEMBL818136 0.83 LMNA (0.63) LMNATSHRTHRB
Butane SCHEMBL10830357 0.83 LMNA (0.50) LMNATSHR
Butane SCHEMBL3144035 0.83 LMNA (0.50) LMNA
Propionaldehyde SCHEMBL8906570 0.81 LMNA (0.60) LMNATSHRTHRB
Butane SCHEMBL8312214 0.81 LMNA (0.60) LMNATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1176 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4206205-B1 PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND PRIMEGENE BEIJING CO LTD (CN) 2026-03-04 EP claimed
US-20250320221-A1 NOVEL INTERMEDIATE, METHOD FOR PREPARING THE SAME AND APPLICATION THEREOF UNIV SICHUAN (CN) 2025-10-16 US claimed
EP-4613745-A2 PROCESS FOR PREPARING A COT INHIBITOR COMPOUND Gilead Sciences, Inc. (US) 2025-09-10 EP claimed
EP-4479405-A1 SYNTHESIS OF BRUTON'S TYROSINE KINASE INHIBITORS JANSSEN Pharmaceutica NV (BE) 2024-12-25 EP claimed
US-11891375-B2 Method for the synthesis of 2,4-dimethylpyrimidin-5-ol, intermediates, and method for the synthesis of Lemborexant using the intermediates MOEHS IBERICA, S.L. (ES) 2024-02-06 US claimed
US-20230303578-A1 PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND PRIMEGENE (BEIJING) CO., LTD. (CN) 2023-09-28 US claimed
WO-2023156599-A1 SYNTHESIS OF BRUTON'S TYROSINE KINASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2023-08-24 WO claimed
EP-4206205-A1 PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND Primegene (Beijing) Co., Ltd. (CN) 2023-07-05 EP claimed
EP-4201926-A1 NOVEL INTERMEDIATE, PREPARATION METHOD FOR SAME, AND APPLICATIONS THEREOF Sichuan University (CN) 2023-06-28 EP claimed
CN-111620764-B Selective ether bond cleavage method of aryl alkyl ether 荆楚理工学院 2023-05-05 CN claimed
US-20080308426-A1 Electrochemical Method for the Production of Betulin Aldehyde REGENTS OF THE UNIVERSITY OF MINNESOTA 2008-12-18 US claimed
WO-2008039414-A1 PROCESS FOR THE PREPARATION OF 4-HYDROXYTHIENO[2,3-B]PYRIDINE-5-CARBONITRILES WYETH (US) 2008-04-03 WO claimed
US-20080076926-A1 Process for the preparation of 4-hydroxythieno[2,3-b]pyridine-5-carbonitriles WYETH 2008-03-27 US claimed
WO-2006105357-A2 ELECTROCHEMICAL METHOD FOR THE PRODUCTION OF BETULIN ALDEHYDE REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2006-10-05 WO claimed
WO-2006068410-A1 NOVEL 3-(2-AMINO-6-PYRIDINYL)-4-HYDROXYPHENYL AMINE DERIVATIVES LG LIFE SCIENCES, LTD. (KR) 2006-06-29 WO claimed
US-5248760-A CHEMICALLY CURED LOW TEMPERATURE POLYIMIDES UNC AT CHARLOTTE (US) 1993-09-28 US claimed
WO-1992013024-A1 CHEMICALLY CURED LOW TEMPERATURE POLYIMIDES THE UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE (US) 1992-08-06 WO claimed
EP-0132024-B1 STABILISED FORMULATION SUITABLE FOR USE IN PYROLYTIC GLASS COATING PROCESS M & T CHEMICALS, INC. (US) 1987-09-30 EP claimed
US-4530857-A Heating glass container; spraying with a monoalkyltin trihalide solution M&T CHEMICALS INC. (US) 1985-07-23 US claimed
EP-0132024-A2 Stabilised formulation suitable for use in pyrolytic glass coating process M & T CHEMICALS, INC. (US) 1985-01-23 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11891375-B2 Method for the synthesis of 2,4-dimethylpyrimidin-5-ol, intermediates, and method for the synthesis of Lemborexant using the intermediates NISCH, DDO, NNT LMNA 662/4885TSHR 3826/4885THRB 3368/4885
US-20230303578-A1 PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND DPYD, RPLP2, DHPS LMNA 4225/4885TSHR 4332/4885THRB 4571/4885
US-20080076926-A1 Process for the preparation of 4-hydroxythieno[2,3-b]pyridine-5-carbonitriles MAP4K2, MAP4K1, MAP4K3 LMNA 2773/4885TSHR 2160/4885THRB 978/4885
US-20250320221-A1 NOVEL INTERMEDIATE, METHOD FOR PREPARING THE SAME AND APPLICATION THEREOF OPRK1, OPRM1, OPRD1 LMNA 4807/4885TSHR 4223/4885THRB 3153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.